Healthcare

Obesity has emerged as one of the most pressing global health challenges, with rising prevalence across both developed and developing economies. Health experts warn that increasing rates of obesity are driving a surge in chronic diseases such as diabetes, cardiovascular disorders and certain cancers. The trend carries significant economic implications, placing additional strain on healthcare systems and reducing workforce productivity.

Vitamin B12 deficiency is increasingly drawing attention from healthcare professionals and policymakers due to its widespread health implications and growing prevalence worldwide. The nutrient plays a critical role in neurological function, red blood cell formation and DNA synthesis. Recent health assessments suggest that a significant portion of the global population—particularly vegetarians, older adults and individuals with digestive disorders—may be at risk of inadequate intake.

Sleep deprivation is emerging as a significant public health concern in India, driven by rapid urbanization, demanding work schedules, and widespread digital device usage. Health experts warn that millions of Indians are sleeping fewer hours than recommended, increasing the risk of chronic illnesses, reduced productivity, and mental health challenges. Medical researchers emphasize that sleep is not merely a lifestyle choice but a biological necessity critical for cognitive function and long-term health.

Human papillomavirus (HPV) has emerged as one of the most closely monitored public health concerns worldwide due to its strong link with cervical cancer and several other diseases. Health organizations and governments are expanding vaccination campaigns and screening programs to reduce the long-term health and economic burden of HPV-related illnesses. Medical research indicates that widespread immunization, early detection and improved healthcare access could dramatically lower infection rates in the coming decades.

Emerging health research has reignited debate about the relationship between rice consumption and the growing prevalence of diabetes, particularly in regions where rice is a staple food. Scientists and nutrition experts are increasingly examining how dietary patterns, portion sizes, and rice varieties influence blood sugar levels and long-term metabolic health. The findings do not suggest eliminating rice entirely but emphasize balanced diets, improved grain choices, and lifestyle awareness.

Global healthcare major Abbott has introduced an advanced drug-eluting coronary stent in India aimed at treating complex arterial blockages that pose challenges during angioplasty procedures. The device, part of the company’s next-generation XIENCE platform, is designed to enhance flexibility, precision and deliverability for cardiologists navigating intricate coronary anatomies. The launch arrives at a critical time as cardiovascular disease continues to surge across India due to rising lifestyle risks such as diabetes, hypertension and obesity.

Emerging scientific evidence continues to reinforce a compelling link between regular physical exercise and improved brain health. Researchers say consistent physical activity not only enhances cardiovascular fitness but also stimulates neurological processes that strengthen memory, focus, and emotional well-being. Studies suggest that moderate exercise increases blood flow to the brain, encourages the growth of new neural connections, and may reduce the risk of neurodegenerative conditions later in life.

Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) is rapidly emerging as one of the most significant public health challenges worldwide. Closely linked to obesity, diabetes and sedentary lifestyles, MASLD affects an estimated one-third of the global population. The condition, previously known as non-alcoholic fatty liver disease, occurs when excess fat accumulates in the liver due to metabolic dysfunction rather than alcohol consumption. While often symptomless in its early stages, MASLD can progress to severe complications including liver fibrosis, cirrhosis and cancer.

Healthcare provider Mom’s Belief has launched an initial public offering (IPO) aimed at raising approximately Rs. 100 crore to support the expansion of its specialized neurodevelopment care services. The funds will primarily be directed toward establishing new therapy centers, strengthening clinical infrastructure, and advancing early intervention programs for children with neurological and developmental conditions. The IPO reflects the company’s ambition to scale its healthcare model amid growing demand for specialized pediatric care in India.

A new class of medications known as GLP-1 receptor agonists is rapidly transforming the global pharmaceutical and healthcare industries. Originally developed to treat Type 2 Diabetes, these drugs are now gaining widespread attention for their effectiveness in managing Obesity and metabolic disorders. Pharmaceutical giants including Novo Nordisk and Eli Lilly and Company are experiencing unprecedented demand for their GLP-1 therapies. The surge in prescriptions has sparked intense competition, regulatory scrutiny and new investment across the biotech sector.